We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Tumor drugs.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

Tumor drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Tumor drugs Product List

1~4 item / All 4 items

Displayed results

[Research Material] Global Market for Hematologic Malignancies

World Market for Hematologic Malignancies: Leukemia, Lymphoma, Myeloma, Hospital Pharmacies, Medical Stores, E-commerce Platforms

This research report (Global Hematological Malignancies Market) investigates and analyzes the current status and outlook for the global market of hematological malignancies over the next five years. It includes information on the overview of the global hematological malignancies market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include leukemia, lymphoma, and myeloma, while the segments by application focus on hospital pharmacies, medical stores, and e-commerce platforms. The regional segments calculate the market size of hematological malignancies by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in hematological malignancies, product and business overviews, and sales performance.

  • Other services
  • Tumor drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Tumor Treatment Drugs

Global Market for Tumor Treatment Drugs: Chemotherapy, Targeted Therapy, Immunotherapy (Biological Therapy), Hormonal Therapy, Others, Hematological Cancers, Breast Cancer, Gastrointestinal Cancers, ...

This research report (Global Oncology Drugs Market) investigates and analyzes the current status and outlook for the global market of oncology drugs over the next five years. It includes information on the overview of the global oncology drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oncology drugs market include chemotherapy, targeted therapy, immunotherapy (biological therapy), hormone therapy, and others, while the segments by application cover hematologic cancers, breast cancer, gastrointestinal cancers, prostate cancer, respiratory cancers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of oncology drugs. It also includes the market share of major companies in oncology drugs, product and business overviews, and sales performance.

  • Other services
  • Tumor drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Wilm's Tumor Treatment

Global Market for Wilms Tumor Treatment: Cabozantinib, SEL-12034, Lacutamab, Others, Hospitals, Clinics, Others

This research report (Global Wilms' Tumor Treatment Market) investigates and analyzes the current state and outlook for the global market for Wilms' tumor treatment over the next five years. It includes information on the overview of the global Wilms' tumor treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Wilms' tumor treatment market include cabozantinib, SEL-12034, lacutamab, and others, while the segments by application include hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Wilms' tumor treatment. It also includes the market share of major companies in Wilms' tumor treatment, product and business overviews, and sales performance.

  • Other services
  • Tumor drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Neuroendocrine Tumor Treatment

World Market for Neuroendocrine Tumor Treatment: Everolimus, Sunitinib, Dota-Octreotate, Lanreotide, Octreotide, Hospitals, Clinics ...

This research report (Global Neuroendocrine Tumor Treatment Market) investigates and analyzes the current state and outlook for the global neuroendocrine tumor treatment market over the next five years. It includes information on the overview of the global neuroendocrine tumor treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the neuroendocrine tumor treatment market focus on everolimus, sunitinib, dotatate, lanreotide, and octreotide, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size for neuroendocrine tumor treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in neuroendocrine tumor treatment, product and business overviews, and sales performance.

  • Other services
  • Tumor drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration